BP11121 PLGA 65:35, Lauryl Ester Terminated, IV: 0.18–0.25 dl/g, Mw: 15–24 kDa

PLGA 65:35, Lauryl Ester Terminated, IV: 0.18–0.25 dl/g, Mw: 15–24 kDa Description

This product is a poly(lactic-co-glycolic acid) copolymer with a 65:35 lactide-to-glycolide ratio, terminally modified with a lauryl ester group. The specified intrinsic viscosity (0.18–0.25 dl/g) and molecular weight (15–24 kDa) ensure consistent degradation and mechanical properties. Its powder form supports integration into various fabrication processes including solvent casting and moulding, making it applicable for drug delivery systems and tissue engineering scaffolds requiring precise bioabsorption profiles.

PLGA 65:35, Lauryl Ester Terminated, IV: 0.18–0.25 dl/g, Mw: 15–24 kDa Applications

Healthcare Applications
   - Use as a matrix in drug delivery systems to achieve controlled release by leveraging its predictable degradation rate. This structured breakdown supports consistent therapeutic dosing.
   - Applied as scaffolding in tissue engineering to promote cellular growth by utilising its biocompatible degradation characteristics.

Research and Development
   - Frequently used for in-vitro studies where reproducible polymer degradation is essential to simulate in vivo conditions by utilising its defined intrinsic viscosity and molecular weight.
   - Serves as a model polymer in formulation studies where predictable biopolymer behaviour enhances experimental reliability.

PLGA 65:35, Lauryl Ester Terminated, IV: 0.18–0.25 dl/g, Mw: 15–24 kDa Packing

This product is packaged in moisture-resistant, sealed foil pouches to limit exposure to ambient humidity and contaminants. Each pouch is placed within a rigid, insulated carton to protect against physical damage during transit. The packaging is designed for long-term storage under controlled temperature conditions. Custom packaging solutions, including anti-static materials and tamper-evident seals, are available to meet specific storage and distribution requirements.

Additional Information

PLGA polymers, known for their biodegradability, are widely studied in fields ranging from pharmaceutical delivery to tissue engineering. Their hydrolysis profile can be tailored by adjusting the lactide-to-glycolide ratio and terminal modifications, offering predictable resorption rates. This adaptability makes them a fundamental component in developing temporary implants and drug release matrices. Understanding the interplay between molecular structure and degradation behaviour is essential for optimising performance in biomedical and research applications.

Regulatory Note: This material is intended for industrial and research applications. It is the customer's responsibility to ensure compliance with all relevant safety and regulatory standards in their intended use.